Form 4: Myriad Genetics Director Rashmi Kumar Sells 7,500 Shares

Director Rashmi Kumar sold 7,500 shares of Myriad Genetics Inc. on August 19, 2024, at a price of $28.01 per share, according to a Form 4 filing.

Summary

• Rashmi Kumar, a director of Myriad Genetics Inc., sold 7,500 shares of common stock on August 19, 2024.
• The sale price was $28.01 per share.
• The transaction was executed under a Rule 10b5-1 trading plan.
• Following the transaction, Rashmi Kumar directly owns 77,392 shares of Myriad Genetics Inc.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a stock sale by a company director. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific inside information.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, such as directors and officers, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, although the use of a 10b5-1 plan mitigates this concern.

Key Dates